Raritan’s Ortho Clinical Diagnostics Holdings plc and Quidel Corp., based in San Diego, on Dec. 23 announced entering a definitive agreement that will see Quidel acquire Ortho in a deal valued at ...
-- Ortho's new VITROS(R) Anti-SARS-CoV-2 Total N test detects the individual's immune response to the COVID-19 virus and is intended to help clinicians understand if their patient had a recent ...
- Ortho's new VITROS ® Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which gives clinicians ...
RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...
Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, and EKF Diagnostics (EKF) today announced an agreement that allows Ortho customers to access to Beta-Hydroxybutyrate (BHB) ...
RARITAN, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient ...
RARITAN, N.J.--(BUSINESS WIRE)--Ortho Clinical Diagnostics today announced the appointments of accomplished industry veterans Carl Hull, Ron Labrum, Thomas Mac Mahon and José (Joe) E. Almeida as ...
Michael Iskra, executive vice president of commercial excellence and strategy at Ortho, said his company is focused on delivering quality results and the operational financial impacts of diagnostic ...
Ortho Clinical Diagnostics is hoping to pay down a large portion of its debts by riding a wave of COVID-19 and broader in vitro lab testing demands to a $1.5 billion IPO. The company is offering 70 ...
Raritan-based Ortho Clinical Diagnostics, a provider of in vitro diagnostics, announced its board of directors appointed Chris Smith as chief executive officer effective Sept. 9th. Smith will succeed ...
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced it is working with Quest ...
In this episode of Industry Focus: Wildcard, host Jason Moser and Motley Fool contributor Brian Feroldi take a closer look at Ortho Clinical Diagnostics' (OCDX +0.00%) debut on the public markets to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results